How often does Erasca appear in global news?

Tracked across 2 news events drawn from 195 articles.

What is Erasca's current news sentiment?

Aggregate sentiment score: -75 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

How prominent is Erasca in global news coverage?

Attention score of 7, derived from article volume and coverage intensity across 2 events.

What is the most recent event involving Erasca?

Erasca faces class action lawsuit (Jun 11, 2026, 6 articles).

Who is Erasca most connected to?

Top relationships: Revolution Medicines (competitor), Revolution Medicines (competitor).

How is this data collected?

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.

Company

Erasca

Tracked across 2 events · 195 articles · First seen May 19, 2026 · Last active Jul 05, 2026

Sentiment

-75

Attention

Events

Relationships

Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard

Events (2)

4 -70

Regulatory

Erasca faces class action lawsuit

Impact: Erasca is the defendant in a class action lawsuit alleging misleading statements regarding its ERAS-0015 drug candidate, which led to a drop in its stock price. The company denies the allegations and intends to contest them.

Jun 11, 2026 · 6 articles

7 -80

Regulatory

Erasca Faces Securities Fraud Lawsuits

Impact: Erasca is the defendant in multiple class action lawsuits alleging securities fraud due to misleading statements about its drug candidate ERAS-0015, patent infringement claims, and a patient death during clinical trials. This has led to a significant drop in its stock price and market capitalization.

May 19, 2026 · 189 articles

Key Actions (20)

100 Robbins LLP filed class action lawsuit Erasca Erasca faces class action lawsuit

100 Bragar Eagel & Squire filed class action lawsuit Erasca Erasca Faces Securities...

90 Erasca stock price fellErasca faces class action lawsuit

90 Erasca made false statementsErasca Faces Securities...

90 Erasca reported preliminary clinical dataErasca Faces Securities...

90 Revolution Medicines sent letter alleging infringement Erasca Erasca faces class action lawsuit

90 Bronstein, Gewirtz & Grossman, LLC filed class action lawsuit Erasca Erasca Faces Securities...

90 Pomerantz LLP filed class action lawsuit Erasca Erasca Faces Securities...

89 Revolution Medicines sent letter alleging infringement Erasca Erasca Faces Securities...

85 Robbins Geller Rudman & Dowd LLP announced class action Erasca Erasca Faces Securities...

85 Hagens Berman filed class action Erasca Erasca Faces Securities...

85 Robbins Geller Rudman & Dowd LLP alleged false statements Erasca Erasca Faces Securities...

80 Erasca disclosed letterErasca faces class action lawsuit

80 Rosen Law Firm announced class action lawsuit Erasca Erasca Faces Securities...

80 Faruqi & Faruqi filed class action Erasca Erasca Faces Securities...

80 Kahn Swick & Foti notifies investors of lawsuit Erasca Erasca Faces Securities...

76 Erasca disclosed letter Revolution Medicines Erasca Faces Securities...

70 Kirby McInerney LLP filed class action lawsuit Erasca Erasca Faces Securities...

70 The Schall Law Firm reminded investors of lawsuit Erasca Erasca Faces Securities...

70 Glancy Prongay & Murray filed class action lawsuit Erasca Erasca Faces Securities...

Relationships (2)

Revolution Medicines competitor ↔ Erasca Erasca is a clinical-stage oncology company that directly competes with Revoluti

Revolution Medicines competitor ↔ Erasca Revolution Medicines is a precision oncology company competing directly against

ERGEN INTELLIGENCE

Track Erasca live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard